Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Solmi M"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 29
Tytuł:
Temporal trends in associations between severe mental illness and risk of cardiovascular disease: A systematic review and meta-analysis.
Autorzy:
Lambert AM; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
Parretti HM; Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
Pearce E; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
Price MJ; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.; NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, United Kingdom.
Riley M; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
Ryan R; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
Tyldesley-Marshall N; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
Avşar TS; Department of Applied Health Research, University College London, London, United Kingdom.
Matthewman G; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
Lee A; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
Ahmed K; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
Odland ML; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.; Department of Obstetrics and Gynecology, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Malawi-Liverpool-Wellcome Trust Research Institute, Blantyre, Malawi.; Institute of Life Course and Medical Sciences, University of Liverpool, United Kingdom.
Correll CU; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, New York, United States of America.; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, New York, United States of America.; Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany.
Solmi M; Department of Psychiatry, University of Ottawa, Ontario, Canada.; Department of Mental Health, The Ottawa Hospital, Ontario, Canada.; Ottawa Hospital Research Institute (OHRI), Clinical Epidemiology Program, University of Ottawa, Ottawa, Ontario, Canada.
Marshall T; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2022 Apr 19; Vol. 19 (4), pp. e1003960. Date of Electronic Publication: 2022 Apr 19 (Print Publication: 2022).
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiovascular Diseases*/epidemiology
Heart Failure*
Mental Disorders*/complications
Mental Disorders*/epidemiology
Psychotic Disorders*
Schizophrenia*/complications
Schizophrenia*/epidemiology
Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Melatonin and melatonin-agonists for metabolic syndrome components in patients treated with antipsychotics: A systematic review and meta-analysis.
Autorzy:
Miola A; Department of Neuroscience, University of Padova, Padua, Italy.; Padua Neuroscience Center, University of Padova, Padua, Italy.
Fornaro M; Section of Psychiatry, Department of Neuroscience, Reproductive Sciences and Dentistry, Federico II University, Naples, Italy.
Sambataro F; Department of Neuroscience, University of Padova, Padua, Italy.; Padua Neuroscience Center, University of Padova, Padua, Italy.
Solmi M; Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada.; Department of Mental Health, The Ottawa Hospital, Ottawa, Ontario, Canada.; Clinical Epidemiology Program, Ottawa Hospital Research Institute (OHRI), University of Ottawa, Ottawa, Ontario, Canada.
Pokaż więcej
Źródło:
Human psychopharmacology [Hum Psychopharmacol] 2022 Mar; Vol. 37 (2), pp. e2821. Date of Electronic Publication: 2021 Oct 22.
Typ publikacji:
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms:
Antipsychotic Agents*/adverse effects
Bipolar Disorder*/drug therapy
Melatonin*/adverse effects
Metabolic Syndrome*/chemically induced
Metabolic Syndrome*/drug therapy
Schizophrenia*/drug therapy
Humans ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Linking cell cycle to mitochondria in schizophrenia: a case-control study using olfactory neuroepitheliumderived neural progenitor cells.
Autorzy:
Idotta, C.
Tibaldi, E.
Pagano, M.
Favaretto, N.
Cazzador, D.
Peruzzo, R.
Solmi, M.
Martini, A.
Leanza, L.
Favaro, A.
Brunati, A. M.
Toffanin, T.
Pokaż więcej
Temat:
CELL cycle
PROGENITOR cells
SCHIZOPHRENIA
SMELL disorders
MITOCHONDRIA
CASE-control method
Źródło:
European Psychiatry; 2022 Special issue S1, Vol. 63, pS409-S409, 1/2p
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 29

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies